Acarbose vs placebo
All‐cause mortality · people at increased risk for developing type 2 diabetes
It is very uncertain whether acarbose changes all‐cause mortality compared with placebo (very low certainty).
1 finding from 1 review
- Alpha‐glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in… 2018 · Cochrane Headline outcomes onlyRR 0.98 [0.82, 1.18]3 studies · 8069 participantsVery low